A recent study revealed that GLUT6 is upregulated in human endometrial cancer and that inhibiting GLUT6 expression with small interfering RNA (siRNA) reduced the glucose uptake and glycolysis and killed human endometrial cancer cells (Byrne et al., 2014). The gene discussed is SLC2A6; the disease is endometrial cancer.